You are here

Complexity

COVID "Long haulers" --more background on their problems

How many people get ‘long COVID’ – and who is most at risk?

A few months ago, a young athletic guy came into my clinic where I’m an infectious disease physician and COVID-19 immunology researcher. He felt tired all the time, and, importantly to him, was having difficulty mountain biking. Three months earlier, he had tested positive for COVID-19. He is the kind of person you might expect to have a few days of mild symptoms before recovering fully. But when he walked into my clinic, he was still experiencing symptoms of COVID-19 and he could not mountain bike at the level he was able to before.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

The difficulties in enrolling teenagers for vaccine test trials.

 

 

Teenagers contract the novel coronavirus almost twice as often as younger children but vaccines authorized in the United States are mostly for adults — Moderna’s for 18 and older, Pfizer’s for 16 and up.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Why Poorer Countries Aren't Likely To Get The Pfizer Vaccine Any Time Soon

This week, the world heard encouraging news about a vaccine for COVID-19.

On Monday, the pharmaceutical company Pfizer, and its partner BioNTech, said their experimental vaccine appears to work – and work quite well. A preliminary analysis suggests the vaccine is more than 90 percent effective at preventing COVID-19 symptoms.

Health officials hope to start vaccinating some Americans in a few months.

"The vaccine is on its way, folks," Dr. Anthony Fauci told a crowd Tuesday, via video link, outside Brooklyn Borough Hall.

But what about the rest of world, especially people in poorer counties. Is the vaccine "on its way for them?"

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Complexity
howdy folks